Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    The SGLT2-inhibitors revolution in Heart Failure. Current indications and future perspectives

    The SGLT2-inhibitors revolution in Heart Failure. Current indications and future perspectives

    FromHFA Cardio Talk

    Start listeningView podcast show

    The SGLT2-inhibitors revolution in Heart Failure. Current indications and future perspectives

    FromHFA Cardio Talk

    ratings:
    Length:
    15 minutes
    Released:
    Feb 21, 2022
    Format:
    Podcast episode

    Description

    With Giuseppe Rosano - St George's Hospital Medical School – London - UK & Antonio Cannata - King's College London, London - UK This podcast will discuss the most recent and serendipitous revolution in the field of Heart Failure, the SGLT2-inhibitors, their indications and future perspectives. Prof Rosano, interviewed by Dr Cannata, will drive through the most recent evidence supporting the use of SGLT2-i in patients with heart failure. Let's see whether an apple a day truly keeps the doctor away.  
    Released:
    Feb 21, 2022
    Format:
    Podcast episode

    Titles in the series (28)

    The HFA Cardio Talk provides the opportunity to anyone interested in Heart Failure to receive updates in the field with very specific and diverse topics, go on a deeper subject of an HFA course and to listen to a discussion of key opinion leaders with junior HF specialists. Each month, a new episode lasting approximately 15 minutes and taking the form of a conversation between a member of the HFA Young community and an internationally renowned expert is released. You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk and ESC TV Today. Check them out!